On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
WednesdayJun 01, 2022 11:15 am

With a Focus on Accountability, Prime Harvest Inc. Continues to Grow as a Leader in California’s Cannabis Industry

Prime Harvest is a California-based tech-driven full-service cannabis corporation focused on direct-to-consumer operations, licensing acquisition, compliance management, and state-wide delivery Prime Harvest fuses integrity into operations, dedicated to redefining the customer experience, being a force for good within the communities they serve, while building a valuable enterprise Member of Community Alliance Program (“CAP”), supports education, arts initiatives, and military veteran organizations in local Southern California Company launched Jaxx Cannabis in 2019, sales increased by 34% in early 2020, hit record 63% gross margin in Q1-2020 From its humble beginnings in 2017 as a cannabis producer in San Diego, Prime Harvest,…

Continue Reading

WednesdayJun 01, 2022 10:30 am

Correlate Infrastructure Partners Inc. (CIPI) Offering Financial Savings and Energy Efficiency Across the Commercial Sector

Corporate issuers are spending over $675,000 annually on climate-related disclosures Institutional investors, on the other hand, spend about $1.4 million to collect, analyze and report climate data Correlate Infrastructure Partners Inc. seeks to offer deep financial savings and energy efficiency by reducing site-specific energy consumption and deploying clean energy generation Through its offering, it aims to help companies and investors cut down on costs associated with climate-related disclosures while also helping them adhere to the new rules and guidelines Companies worldwide are facing increasing pressure to provide climate-related disclosures. Regulators have been at the forefront of demanding these releases in…

Continue Reading

WednesdayJun 01, 2022 9:45 am

Kronos Advanced Technologies Inc. (KNOS) Committed to Providing Best Protection, Best Technology Amid Lingering Pandemic

WHO director-general warns COVID-19 is “most certainly not over” KNOS building reputation for effective, advanced, state-of-the-art air filtration and purification systems Company also offers Kronos(R)-designed graphene N95 face masks made in U.S. at NIOSH-certified facility While mask mandates have been lifted and life appears to be returning to normal in many places around the world, the COVID-19 pandemic is “most certainly not over,” reported Tedros Adhanom Ghebreyesus, director-general of the World Health Organization (https://ibn.fm/8YfkT). The need for continued vigilance has spurred many companies, including Kronos Advanced Technologies (OTC: KNOS), that are working to provide people with protection against the deadly…

Continue Reading

WednesdayJun 01, 2022 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Technology Consistently Enhancing the Oral Administration of Active Pharmaceutical Ingredients

A global innovator in drug delivery platforms, Lexaria has developed a patented technology, DehydraTECH(TM) Through research, Lexaria has evidenced that DehydraTECH enhances the efficiency and speed of orally- administered fat-soluble active pharmaceutical ingredients (“APIs”) Lexaria is consistently enhancing the delivery of APIs that affect current oral formulations: speed of onset, limited absorption, and low membrane permeability Lexaria has conducted numerous ground-breaking studies, some of which open up the possibility of fast-acting oral products that avoid the lung diseases and cancers caused by inhalation of combusted molecules common in smoking Oral formulations account for approximately 90% of the global share of…

Continue Reading

TuesdayMay 31, 2022 3:00 pm

DGE’s 2nd KOL Engagement Forum Designed To Foster Partnership Ties With KOLs

Life science companies and professionals are invited to attend Dynamic Global Events’ (“DGE”) 2nd KOL Engagement Forum, livestreaming June 1-2, 2022. A pioneer in organizing networking events, Dynamic Global Events focuses on delivering high-quality data and networking avenues to the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries.  The forum is designed for medical and life science professionals to create strong networking ties and cultivate strong long-term relationships with the most influential thought leaders in the industry. In these uncertain times when there is growing distrust for institutions, these respected partnerships will foster confidence and lend credibility to the products. KOLs…

Continue Reading

TuesdayMay 31, 2022 12:45 pm

Social Media & Influencer Strategies Summit to Cover All Aspects of Social Media Marketing and Influencer Marketing Strategies

The Social Media & Influencer Strategies Summit promises to bridge the “best of both worlds,” conflating two conferences set to be held over four days. Organized by GSMI Events, the virtual event scheduled for June 7-10 includes a two-day Social Media Summit set for June 7 and 8, in which the speakers and panelists will focus their talks on social media marketing and content strategy, and an Influencer Summit subsequently slated for June 9 and 10. The latter will feature influencer-marketing-focused case studies and talks delivered by leading figures in the influencer segment. Attendees will get to hear from 50…

Continue Reading

TuesdayMay 31, 2022 12:00 pm

CWCBExpo, the Premier B2B Cannabis, and Hemp Expo and Conference to Foster Lively Discussion on Industry Opportunities and Challenges Among Seasoned Professionals and Newcomers Alike

The Cannabis World Congress & Business Exposition (CWCBExpo) will be held between June 2-4, 2022, at the Javits Convention Center, Hall 3A, in New York City. Industry heavyweights, the foremost innovators, and pioneering thought leaders will take the stage to discuss emerging trends in cannabis, hemp, and allied sectors. The expo will provide a high-quality business-focused attendee base located in the premier East Coast US cannabis and hemp market.  The three-day event will feature an Inside the Industry: Thought Leadership Series in an interactive “Talk Show” format. Co-hosts will include Carl Cameron, veteran journalist and former FOX News reporter; Faye…

Continue Reading

TuesdayMay 31, 2022 11:15 am

Silo Pharma Inc. (SILO) Focuses on Psilocybin’s Anti-Inflammatory Properties

On May 19, 2022, Silo Pharma (OTCQB: SILO) announced that The Translational Psychedelic Research (“TrPR”) Program at UCSF (University of California San Francisco) had “successfully dosed [with psilocybin] patients suffering from Parkinson’s disease.” TrPR connects researchers and medical professionals studying how psychedelics, including psilocybin, ketamine, etc., affect brain functions and other organ systems. Silo Pharma focuses on palliative uses of psychedelics for “PTSD, Parkinson’s, and other rare neurological disorders.” In teaming up with TrPR. Silo is exploring psilocybin’s anti-inflammatory possibilities in patients exhibiting signs of Parkinson’s Disease.  Psilocybin’s journey from magic mushrooms to potential life savers has been a long,…

Continue Reading

TuesdayMay 31, 2022 10:30 am

Mullen Automotive Inc. (NASDAQ: MULN) Working to Alleviate Consumer Anxiety by Offering EVs with 600-Plus Mile Range

J.D. Power survey reports range was factor most cited in deciding what EV to buy Mullen is making significant strides toward producing vehicles that feature some of the longest ranges available in the EV space Recognizing the critical role of battery and range in the success of an EV, Mullen is exploring other advanced battery technologies One of the challenges preventing enthusiastic acceptance of electric vehicles is range anxiety, fear that an electric car will run out of battery or fuel before the driver can reach their destination or a charging station. The concern is valid — a January 2022…

Continue Reading

TuesdayMay 31, 2022 9:45 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) and Kernel Report Result of Study Measuring Ketamine’s Effects on the Brain

Study shows that COVID-19 pandemic has affected mental health of 59% of U.S. population, intensifying already-serious issue CYBN-sponsored feasibility study indicates ketamine-induced changes in brain’s functional connectivity persisted for several days after receiving the substance Kernel Flow pivotal in developing most accurate, effective treatment regimens for patients The challenges associated with mental-health issues are rising, following the global pandemic. Already a serious problem before COVID-19, mental health has become even more pressing now, with many companies committed to offering relief to the nearly 1 billion people worldwide who deal with mental-health issues. Cybin (NEO: CYBN) (NYSE American: CYBN), a clinical-stage biopharmaceutical…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered